Department of Health
and Human Services (HHS)
and Human Services (HHS)
August 19, 2021
PA-18-939 - Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
This notice informs applicants of an extension to Funding Opportunity Announcement (FOA) PA-18-939 "Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)". ThisFOA) has been extended by one additional council round. The following due dates have been added: New Application due date: February 16, 2022; Resubmission, Revision, Renewal Due Date: March 16, 2022. This FOA will expire May 8, 2022.
The following section of PA-18-939 has been modified:
Currently Reads:
Part 1. Overview Information
Key Dates:
| Application Due Date(s) | Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Expiration Date | January 8, 2022 |
Modified to Read (change shown in bold italics):
Part 1. Overview Information
Key Dates:
| Application Due Date(s) | Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Expiration Date | May 8, 2022 |
All other aspects of this FOA remain unchanged.
Michael L. Oshinsky, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9964
Email: [email protected]